MEIS2_HUMAN - dbPTM
MEIS2_HUMAN - PTM Information in dbPTM
Basic Information of Protein
UniProt ID MEIS2_HUMAN
UniProt AC O14770
Protein Name Homeobox protein Meis2
Gene Name MEIS2
Organism Homo sapiens (Human).
Sequence Length 477
Subcellular Localization Nucleus . Cytoplasm, perinuclear region .
Protein Description Involved in transcriptional regulation. Binds to HOX or PBX proteins to form dimers, or to a DNA-bound dimer of PBX and HOX proteins and thought to have a role in stabilization of the homeoprotein-DNA complex. Isoform 3 is required for the activity of a PDX1:PBX1b:MEIS2b complex in pancreatic acinar cells involved in the transcriptional activation of the ELA1 enhancer; the complex binds to the enhancer B element and cooperates with the transcription factor 1 complex (PTF1) bound to the enhancer A element; MEIS2 is not involved in complex DNA-binding. Probably in complex with PBX1, is involved in transcriptional regulation by KLF4. Isoform 3 and isoform 4 can bind to a EPHA8 promoter sequence containing the DNA motif 5'-CGGTCA-3'; in cooperation with a PBX protein (such as PBX2) is proposed to be involved in the transcriptional activation of EPHA8 in the developing midbrain. May be involved in regulation of myeloid differentiation. Can bind to the DNA sequence 5'-TGACAG-3'in the activator ACT sequence of the D(1A) dopamine receptor (DRD1) promoter and activate DRD1 transcription; isoform 5 cannot activate DRD1 transcription..
Protein Sequence MAQRYDELPHYGGMDGVGVPASMYGDPHAPRPIPPVHHLNHGPPLHATQHYGAHAPHPNVMPASMGSAVNDALKRDKDAIYGHPLFPLLALVFEKCELATCTPREPGVAGGDVCSSDSFNEDIAVFAKQVRAEKPLFSSNPELDNLMIQAIQVLRFHLLELEKVHELCDNFCHRYISCLKGKMPIDLVIDERDGSSKSDHEELSGSSTNLADHNPSSWRDHDDATSTHSAGTPGPSSGGHASQSGDNSSEQGDGLDNSVASPGTGDDDDPDKDKKRQKKRGIFPKVATNIMRAWLFQHLTHPYPSEEQKKQLAQDTGLTILQVNNWFINARRRIVQPMIDQSNRAGFLLDPSVSQGAAYSPEGQPMGSFVLDGQQHMGIRPAGLQSMPGDYVSQGGPMGMSMAQPSYTPPQMTPHPTQLRHGPPMHSYLPSHPHHPAMMMHGGPPTHPGMTMSAQSPTMLNSVDPNVGGQVMDIHAQ
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
138PhosphorylationRAEKPLFSSNPELDN
HCCCCCCCCCHHHHH
36.5727732954
139PhosphorylationAEKPLFSSNPELDNL
CCCCCCCCCHHHHHH
49.4127732954
180UbiquitinationHRYISCLKGKMPIDL
HHHHHHHCCCCCEEE
61.89-
195PhosphorylationVIDERDGSSKSDHEE
EEECCCCCCCCCCCH
38.5927794612
196PhosphorylationIDERDGSSKSDHEEL
EECCCCCCCCCCCHH
41.5327794612
198PhosphorylationERDGSSKSDHEELSG
CCCCCCCCCCCHHCC
46.2622617229
204PhosphorylationKSDHEELSGSSTNLA
CCCCCHHCCCCCCCC
39.6523663014
206PhosphorylationDHEELSGSSTNLADH
CCCHHCCCCCCCCCC
30.5223663014
207PhosphorylationHEELSGSSTNLADHN
CCHHCCCCCCCCCCC
25.4923663014
208PhosphorylationEELSGSSTNLADHNP
CHHCCCCCCCCCCCC
35.6323663014
216PhosphorylationNLADHNPSSWRDHDD
CCCCCCCCCCCCCCC
48.1024117733
217PhosphorylationLADHNPSSWRDHDDA
CCCCCCCCCCCCCCC
27.6424117733

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources

Oops, there are no upstream regulatory protein records of MEIS2_HUMAN !!

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of MEIS2_HUMAN !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of MEIS2_HUMAN !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
PBX1_HUMANPBX1physical
20211142
TRI25_HUMANTRIM25physical
20211142
ZNHI3_HUMANZNHIT3physical
20211142
A4_HUMANAPPphysical
21832049
MEIS2_HUMANMEIS2physical
25416956
OSGI1_HUMANOSGIN1physical
25416956
CA094_HUMANC1orf94physical
25416956
MEIS3_HUMANMEIS3physical
26186194
MEIS1_HUMANMEIS1physical
26186194
PBX1_HUMANPBX1physical
26186194
PBX2_HUMANPBX2physical
26186194
PBX4_HUMANPBX4physical
26186194
PBX3_HUMANPBX3physical
26186194
GBB4_HUMANGNB4physical
26186194
PIGL_HUMANPIGLphysical
26186194
MEIS3_HUMANMEIS3physical
28514442
PBX2_HUMANPBX2physical
28514442
PBX4_HUMANPBX4physical
28514442
PBX3_HUMANPBX3physical
28514442
PBX1_HUMANPBX1physical
28514442
MEIS1_HUMANMEIS1physical
28514442
PIGL_HUMANPIGLphysical
28514442
ACTB_HUMANACTBphysical
28514442

Drug and Disease Associations
Kegg Disease
There are no disease associations of PTM sites.
OMIM Disease
There are no disease associations of PTM sites.
Kegg Drug
There are no disease associations of PTM sites.
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of MEIS2_HUMAN

loading...

Related Literatures of Post-Translational Modification

TOP